Business Model
Veterinary Vaccines & Antibody Drugs
epitoMAP Inc. plans to generate revenue from the manufacturing and sales of therapeutics and be involved in all stages of drug development, including non-clinical and clinical trials, approval, and commercialization. As for overseas expansion, we plan to provide development and manufacturing licenses to Japanese or overseas companies in animal pharmaceutical industry.
Human Vaccines & Antibody Drugs
We plan to generate revenue by providing epitoMAP’s clinical data for veterinary therapeutics as well as development and manufacturing licenses to Japanese or overseas animal pharmaceutical companies.
epitoMAP will use achievement of 7-year collaborative research with RIKEN Vaccine Innovation Laboratory and AACL to make pharmaceuticals.
